Drug profile · INN
ursodeoxycholic acid
URSOFALK
ursodeoxycholic acid (URSOFALK) is a bile acid receptor fxr agonist. Associated with Lacuna Pharma Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 5
News articles 0
Drug details — ursodeoxycholic acid
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 5
- Data quality
- 0.81
Quick answer
ursodeoxycholic acid (URSOFALK) is a bile acid receptor fxr agonist. Associated with Lacuna Pharma Pty Ltd.
Key facts
INN ursodeoxycholic acid
Brand URSOFALK
Mechanism Bile acid receptor FXR agonist
Target Bile acid receptor
Originator Lacuna Pharma Pty Ltd
Mechanism of action
Bile acid receptor FXR agonist
Primary target: Bile acid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is ursodeoxycholic acid?
ursodeoxycholic acid (URSOFALK) is a bile acid receptor fxr agonist. Associated with Lacuna Pharma Pty Ltd.
What is the brand name for ursodeoxycholic acid?
URSOFALK is a marketed brand name for ursodeoxycholic acid. Check FDA Drugs@FDA for the current US label holder and prescribing information.